<meta charset="utf-8"><div style="text-align: center; font-size: 13px; border-collapse: collapse; font-family: arial, sans-serif; "><span style="font-family: 'times new roman', serif; font-size: large; "><font color="#660000"><b><span><span>STS </span></span><span><span>Circle </span></span>at Harvard</b></font></span></div>
<div style="text-align: center; font-size: 13px; border-collapse: collapse; font-family: arial, sans-serif; "><span style="font-size: x-small; "><i><img src="http://samuelevansresearch.org/random/STS_circle/line.gif" alt="line.gif" title="line.gif" width="420" height="6"><br>
</i></span></div><div style="border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; "><div style="text-align: center; color: rgb(80, 0, 80); font-size: 13px; "><span style="font-size: large; "><b><br>
</b></span></div><div style="text-align: center; color: rgb(80, 0, 80); font-size: 13px; "><span style="font-size: large; "><b><font color="#000000">Anne Pollock<br></font></b></span></div><div style="text-align: center; font-size: 13px; ">
<i>Georgia Tech</i></div><div style="text-align: center; color: rgb(80, 0, 80); font-size: 13px; "><i><font color="#000000"><br></font></i></div><div style="text-align: center; color: rgb(80, 0, 80); font-size: 13px; "><span style="font-size: small; "><font color="#000000">on</font></span></div>
<div style="text-align: center; font-size: 13px; "><br></div><div style="text-align: center; "><span style="font-size: large; "><b>Big Pharma Stagnant and Dynamic: Transforming the Critique</b></span></div><div style="text-align: center; ">
<span style="font-size: large; "><b></b></span> </div><div style="text-align: center; color: rgb(80, 0, 80); font-size: 13px; "><font color="#000000">Monday, December 6th</font></div><div style="text-align: center; color: rgb(80, 0, 80); font-size: 13px; ">
<font color="#000000">12:15-2:00 p.m.</font></div><div style="text-align: center; color: rgb(80, 0, 80); font-size: 13px; "><font color="#000000">124 Mt. Auburn Street, Suite 100, Room 106</font></div><div style="text-align: center; color: rgb(80, 0, 80); font-size: 13px; ">
<font color="#000000"><br></font></div></div><div style="text-align: center; font-size: 13px; border-collapse: collapse; font-family: arial, sans-serif; "><img src="http://samuelevansresearch.org/random/STS_circle/line.gif" alt="line.gif" title="line.gif" width="420" height="6"><br>
</div><div><div style="text-align: center; border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; "><br></div><div style="text-align: center; color: rgb(80, 0, 80); border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; ">
<font color="#000000">Lunch is provided if you RSVP.</font></div><div style="text-align: center; color: rgb(80, 0, 80); border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; "><font color="#000000">Please RSVP to </font><font color="#000000" style="color: rgb(0, 101, 204); "><span><span><a href="mailto:sts@hks.harvard.edu" target="_blank" style="color: rgb(0, 101, 204); ">sts</a></span></span><a href="mailto:sts@hks.harvard.edu" target="_blank" style="color: rgb(0, 101, 204); ">@hks.harvard.edu</a> </font><font color="#000000">by 5pm Thursday, December 2nd.</font></div>
<div style="text-align: left; color: rgb(80, 0, 80); border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; "><font color="#000000"> </font></div><div style="text-align: left; border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; ">
<b><br></b></div><div style="text-align: left; border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; "><b style="border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; ">Abstract:</b><font face="arial, sans-serif"><span style="border-collapse: collapse; "> Intersecting fields of scholarship have accounted for pharmaceutical companies' extraordinary success in promoting and profiting from their wares. This article instead tracks resistances and failures in the terrain of Big Pharma amid economic, epistemological, and political challenges to their business models. Pfizer has been a key player in the rise of Big Pharma, and its fortunes since 2006 provide windows into the industry's stagnation - the failure of Pfizer's would-be blockbuster torcetrapib, the closing of its heart disease research unit, its free drug program for newly unemployed Americans. These illustrate transformations in "least neglected diseases" and in pricing structures, and can be understood in the contexts of both biotech and Global South critique. Biotech companies have remained profitable by creating biologics for niche subsets of rich populations with a high willingness to pay (including lucrative treatments I call "drugs for short lives"). At the same time, dominant global capitalists/philanthropists have brought unprecedented funding to making treatment for AIDS and TB available to the poor and tackling long-neglected diseases like malaria. Now that pharmaceutical profits and markets seem less than infinite in their expansion and philanthropy has been pharmaceuticalized, the stakes of demands like "medicine for people not for profit" are changing. STS critique of pharmaceuticals should take these transformations into account as it deepens its systemic critique of global inequality.</span></font></div>
<div style="text-align: left; border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; "><br></div><div style="text-align: left; "><b style="border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; ">Biography</b><font class="Apple-style-span" face="arial, sans-serif"><span class="Apple-style-span" style="border-collapse: collapse;">: Anne Pollock is an Assistant Professor of Science, Technology and Culture in the School of Literature, Communication and Culture at Georgia Tech. </span></font><span class="Apple-style-span" style="font-family: arial, sans-serif; border-collapse: collapse; ">Trained in the interdisciplinary field of Science, Technology & Society at MIT, her research focuses on biomedicine and culture. She is particularly interested in how medical categories and technologies are enrolled in telling stories about identity and difference, especially with regard to race, gender, and citizenship. </span><span class="Apple-style-span" style="font-family: arial, sans-serif; border-collapse: collapse; ">She is currently revising her book manuscript about the intersecting trajectories of race, pharmaceuticals, and cardiovascular disease in the United States from the founding of cardiology to the commercial failure of BiDil. She is also engaged in two ongoing projects: one about feminism and heart disease, and the other about global pharmaceuticals amid economic crisis and the pharmaceuticalization of philanthropy.</span></div>
<div style="text-align: left; color: rgb(80, 0, 80); border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; "><font color="#000000"><br></font></div><div style="text-align: center; color: rgb(80, 0, 80); border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; ">
<font color="#000000">A complete list of <span><span>STS </span></span><span><span>Circle </span></span>at Harvard events can be found on our website:</font></div><div style="text-align: center; color: rgb(80, 0, 80); border-collapse: collapse; font-family: arial, sans-serif; font-size: 13px; ">
<a href="http://www.hks.harvard.edu/sts/events/sts_circle/" target="_blank" style="color: rgb(0, 101, 204); "><font color="#000000">http://www.hks.harvard.edu/<span><span>sts</span></span>/events/sts_circle/</font></a></div>
</div>